A new protein containing an SH2 domain that inhibits JAK kinases

被引:1228
作者
Endo, TA
Masuhara, M
Yokouchi, M
Suzuki, R
Sakamoto, H
Mitsui, K
Matsumoto, A
Tanimura, S
Ohtsubo, M
Misawa, H
Miyazaki, T
Leonor, N
Taniguchi, T
Fujita, T
Kanakura, Y
Komiya, S
Yoshimura, A
机构
[1] KURUME UNIV,INST LIFE SCI,KURUME 839,JAPAN
[2] KURUME UNIV,DEPT ORTHOPED SURG,KURUME 839,JAPAN
[3] UNIV TOKYO,FAC MED,DEPT IMMUNOL,BUNKYO KU,TOKYO 113,JAPAN
[4] TOKYO METROPOLITAN INST MED SCI,DEPT TUMOR CELL BIOL,BUNKYO KU,TOKYO 113,JAPAN
[5] OSAKA UNIV,SCH MED,DEPT HEMATOL & ONCOL,SUITA,OSAKA 565,JAPAN
关键词
D O I
10.1038/43213
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The proliferation and differentiation of cells of many Lineages are regulated by secreted proteins known as cytokines. Cytokines exert their biological effect through binding to cell-surface receptors that are associated with one or more members of the JAK family of cytoplasmic tyrosine kinases. Cytokine-induced receptor dimerization leads to the activation of JAKs, rapid tyrosine-phosphorylation of the cytoplasmic domains, and subsequent recruitment of various signalling proteins, including members of the STAT family of transcription factors, to the receptor complex(1-5). Using the yeast two-hybrid system, we have now isolated a new SH2-domain-containing protein, TAB, which is a JAK-binding protein that interacts with the Jak2 tyrosine-kinase JH1 domain(6). JAB is structurally related to CIS, a cytokine-inducible SH2 protein(7,8). Interaction of JAB with Jak1, Jak2 or Jak3 markedly reduces their tyrosine-kinase activity and suppresses the tyrosine-phosphorylation and activation of STATs. TAB and CIS appear to function as negative regulators in the JAK signalling pathway.
引用
收藏
页码:921 / 924
页数:4
相关论文
共 22 条
[1]   Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state [J].
Briscoe, J ;
Rogers, NC ;
Witthuhn, BA ;
Watling, D ;
Harpur, AG ;
Wilks, A ;
Stark, GR ;
Ihle, JN ;
Kerr, IM .
EMBO JOURNAL, 1996, 15 (04) :799-809
[2]   JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421
[3]   Activation of Jak2 catalytic activity requires phosphorylation of Y-1007 in the kinase activation loop [J].
Feng, J ;
Witthuhn, BA ;
Matsuda, T ;
Kohlhuber, F ;
Kerr, IM ;
Ihle, JN .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (05) :2497-2501
[4]  
HARPER JW, 1993, CELL, V75, P805
[5]  
HARPUR AG, 1992, ONCOGENE, V7, P1347
[6]   CYTOKINE RECEPTOR SIGNALING [J].
IHLE, JN .
NATURE, 1995, 377 (6550) :591-594
[7]   STATs: Signal transducers and activators of transcription [J].
Ihle, JN .
CELL, 1996, 84 (03) :331-334
[8]  
KAWAHARA A, 1995, P NATL ACAD SCI US, V92, P8721
[9]   CONSTITUTIVELY ACTIVATING MUTATIONS OF C-KIT RECEPTOR TYROSINE KINASE CONFER FACTOR-INDEPENDENT GROWTH AND TUMORIGENICITY OF FACTOR-DEPENDENT HEMATOPOIETIC-CELL LINES [J].
KITAYAMA, H ;
KANAKURA, Y ;
FURITSU, T ;
TSUJIMURA, T ;
ORITANI, K ;
IKEDA, H ;
SUGAHARA, H ;
MITSUI, H ;
KANAYAMA, Y ;
KITAMURA, Y ;
MATSUZAWA, Y .
BLOOD, 1995, 85 (03) :790-798
[10]   CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation [J].
Matsumoto, A ;
Masuhara, M ;
Mitsui, K ;
Yokouchi, M ;
Ohtsubo, M ;
Misawa, H ;
Miyajima, A ;
Yoshimura, A .
BLOOD, 1997, 89 (09) :3148-3154